Aude Lecrubier
- Indexed articles, last 90 days
- 6
- Latest publication
- Sep 8, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 13, 2026
Latest articles
Xylitol Linked to Increased Long-Term Cardiovascular Risk (opens the original)
Read excerpt
MUNICH — A large German study presented at the European Society of Cardiology (ESC) Congress 2026 showed that high blood levels of xylitol — a widely used natural sweetener also known as “birch sugar” — were associated with an increased long-term risk for major adverse cardiovascular events in the general population. In a study published in 2024, Marco Witkowski, MD, PhD, from the Charité University Hospital in Berlin, Germany, and his team had already shown that in 1157 stable patients with a h
Aeson Artificial Heart Delivers in Advanced Heart Failure (opens the original)
Read excerpt
MUNICH — Nine months after its takeover by industrialist Pierre Bastid and following bankruptcy proceedings earlier this year, the French medical device company CARMAT may finally have some good news. Results from the EFICAS study evaluating the clinical performance of the fully implantable Aeson total artificial heart (TAH) were presented at the European Society of Cardiology (ESC) Congress 2026 by André Vincentelli, MD, PhD, of Lille University Hospital and the Lille Heart and Lung Institute i
Pediatric Eye Emergencies: 4 Red Flags Not to Miss (opens the original)
Read excerpt
“It is essential to promptly recognize ophthalmic emergencies in children to optimize both visual outcomes and overall prognosis,” said Guylène Le Meur, MD, ophthalmologist and professor at the University Hospital Nantes (CHU de Nantes), Nantes, France, during a press briefing ahead of the 132nd Congress of the French Society of Ophthalmology (SFO), held May 9-11, 2026, in Paris, France. Delayed diagnosis can have consequences that extend beyond vision loss. “A delay in diagnosis or treatment, e
First-in-Human Gene Editing Trial: What Went Wrong? (opens the original)
Read excerpt
The death of a 6-year-old girl after receiving experimental gene editing therapy at a hospital in Shanghai was not publicly disclosed, prompting an official investigation. A report published by Science, produced in collaboration with Retraction Watch and supported by the Science Fund for Investigative Reporting, has drawn comparisons with the 2018 scandal involving Chinese biophysicist He Jiankui, who secretly created the world’s first gene-edited babies. The girl’s death occurred just 1 month b
GLP-1 Drugs: Is Ozempic Face Changing Aesthetic Care? (opens the original)
Read excerpt
The growing use of GLP-1 receptor agonists (RAs) for weight management is creating new challenges for aesthetic medicine, particularly in managing the physical changes associated with rapid weight loss. “While these drugs are revolutionizing weight management, they also present new aesthetic challenges,” Nicolas Georgieu, MD, president of the French Society of Aesthetic and Plastic Surgeons (SOFCEP), said. “Loss of facial volume, skin laxity, and changes in skin quality mean practitioners must n
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.